StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

TFA Therapeutics's enterprise value was $1.02B on Oct 16, 2026, against $1.02B a year earlier. Over the last 2 years it ranged from $4.85M to $1.02B, with a median of $1.02B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 16, 2026$1.02B+0.0%
2025Dec 31, 2025$1.02B+11.2%
2024Dec 31, 2024$917.15M–

More TFA Therapeutics figures

See a number that looks wrong?